
Yun H. Lee
Examiner (ID: 7036)
| Most Active Art Unit | 3766 |
| Art Unit(s) | 3766 |
| Total Applications | 267 |
| Issued Applications | 215 |
| Pending Applications | 3 |
| Abandoned Applications | 49 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18057963
[patent_doc_number] => 20220389049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => REVERSIBLE TERMINATORS FOR DNA SEQUENCING AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/815725
[patent_app_country] => US
[patent_app_date] => 2022-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18491
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17815725
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/815725 | REVERSIBLE TERMINATORS FOR DNA SEQUENCING AND METHODS OF USING THE SAME | Jul 27, 2022 | Pending |
Array
(
[id] => 19490522
[patent_doc_number] => 12109206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders
[patent_app_type] => utility
[patent_app_number] => 17/872575
[patent_app_country] => US
[patent_app_date] => 2022-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7397
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17872575
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/872575 | Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders | Jul 24, 2022 | Issued |
Array
(
[id] => 18226788
[patent_doc_number] => 20230065782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 17/812657
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812657
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812657 | TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDES | Jul 13, 2022 | Pending |
Array
(
[id] => 19188155
[patent_doc_number] => 20240167068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => METHOD FOR RNA MANUFACTURING
[patent_app_type] => utility
[patent_app_number] => 18/569372
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569372
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/569372 | METHOD FOR RNA MANUFACTURING | Jun 29, 2022 | Pending |
Array
(
[id] => 19896912
[patent_doc_number] => 12274808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-15
[patent_title] => Collagen-based therapeutic delivery systems
[patent_app_type] => utility
[patent_app_number] => 17/854139
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 10998
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17854139
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/854139 | Collagen-based therapeutic delivery systems | Jun 29, 2022 | Issued |
Array
(
[id] => 19418797
[patent_doc_number] => 20240294920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => MODULATION OF NOX4 EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/569084
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30706
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569084
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/569084 | MODULATION OF NOX4 EXPRESSION | Jun 29, 2022 | Pending |
Array
(
[id] => 17958569
[patent_doc_number] => 20220339149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => PALONOSETRON FORMULATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/851017
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851017
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/851017 | PALONOSETRON FORMULATIONS AND USES THEREOF | Jun 26, 2022 | Abandoned |
Array
(
[id] => 18364655
[patent_doc_number] => 20230146246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => Method of Modulating the Number and the Distribution of Tumor-Infiltrating Leukocytes in Tumors
[patent_app_type] => utility
[patent_app_number] => 17/844037
[patent_app_country] => US
[patent_app_date] => 2022-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36366
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17844037
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/844037 | Method of Modulating the Number and the Distribution of Tumor-Infiltrating Leukocytes in Tumors | Jun 18, 2022 | Pending |
Array
(
[id] => 19404008
[patent_doc_number] => 20240287519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => TREATMENT OF DKK2 RELATED DISEASES AND DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/569113
[patent_app_country] => US
[patent_app_date] => 2022-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569113
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/569113 | TREATMENT OF DKK2 RELATED DISEASES AND DISORDERS | Jun 16, 2022 | Pending |
Array
(
[id] => 19402289
[patent_doc_number] => 20240285800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => Retinal Disorders
[patent_app_type] => utility
[patent_app_number] => 18/570701
[patent_app_country] => US
[patent_app_date] => 2022-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570701
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/570701 | Retinal Disorders | Jun 16, 2022 | Pending |
Array
(
[id] => 17911197
[patent_doc_number] => 20220313592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => Liquid Thickener Composition Comprising Polyalkoxylated
[patent_app_type] => utility
[patent_app_number] => 17/838499
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 330
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838499
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/838499 | Liquid Thickener Composition Comprising Polyalkoxylated | Jun 12, 2022 | Abandoned |
Array
(
[id] => 17911198
[patent_doc_number] => 20220313593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => Topical preparations comprising polyalkoxylated polyols polyester
[patent_app_type] => utility
[patent_app_number] => 17/838503
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838503
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/838503 | Topical preparations comprising polyalkoxylated polyols polyester | Jun 12, 2022 | Abandoned |
Array
(
[id] => 19777384
[patent_doc_number] => 12226404
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Methods for making compositions for pulmonary administration
[patent_app_type] => utility
[patent_app_number] => 17/836067
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 15
[patent_no_of_words] => 13430
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836067
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836067 | Methods for making compositions for pulmonary administration | Jun 8, 2022 | Issued |
Array
(
[id] => 18178692
[patent_doc_number] => 20230039421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => RESIDENCE STRUCTURES AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/836972
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836972
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836972 | RESIDENCE STRUCTURES AND RELATED METHODS | Jun 8, 2022 | Pending |
Array
(
[id] => 18716491
[patent_doc_number] => 11793813
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Pemetrexed formulations
[patent_app_type] => utility
[patent_app_number] => 17/835236
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 9355
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835236
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/835236 | Pemetrexed formulations | Jun 7, 2022 | Issued |
Array
(
[id] => 19497921
[patent_doc_number] => 20240336939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => CRISPR INDUCED DISRUPTION OF MOGS GENE
[patent_app_type] => utility
[patent_app_number] => 18/566446
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18566446
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/566446 | CRISPR INDUCED DISRUPTION OF MOGS GENE | Jun 1, 2022 | Pending |
Array
(
[id] => 20179739
[patent_doc_number] => 20250263697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-21
[patent_title] => COMPOSITIONS AND METHODS OF MODULATING RNA AND PROTEIN INTERACTIONS
[patent_app_type] => utility
[patent_app_number] => 18/565689
[patent_app_country] => US
[patent_app_date] => 2022-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18565689
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/565689 | COMPOSITIONS AND METHODS OF MODULATING RNA AND PROTEIN INTERACTIONS | May 31, 2022 | Pending |
Array
(
[id] => 19684365
[patent_doc_number] => 20250002910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => TREATMENT OF COMPLEMENT-MEDIATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/563184
[patent_app_country] => US
[patent_app_date] => 2022-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563184
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/563184 | TREATMENT OF COMPLEMENT-MEDIATED DISORDERS | May 25, 2022 | Pending |
Array
(
[id] => 19318647
[patent_doc_number] => 20240240190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => INHIBITORS OF MITOFERRIN-2 FOR USE IN TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 18/562167
[patent_app_country] => US
[patent_app_date] => 2022-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562167
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/562167 | INHIBITORS OF MITOFERRIN-2 FOR USE IN TREATING CANCER | May 19, 2022 | Pending |
Array
(
[id] => 18270810
[patent_doc_number] => 20230092052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => INTERPENETRATING NETWORK HYDROGELS WITH INDEPENDENTLY TUNABLE STIFFNESS
[patent_app_type] => utility
[patent_app_number] => 17/748330
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748330
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/748330 | INTERPENETRATING NETWORK HYDROGELS WITH INDEPENDENTLY TUNABLE STIFFNESS | May 18, 2022 | Abandoned |